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The bacterium Rickettsia prowazekii is the etiological agent of epidemic typhus, 
a  disease of humans in which rickettsiae proliferate within the endothelial cells 
lining the capillaries. The rickettsiae grow freely in the cytoplasm of their host 
cells; they are not enclosed within vacuoles. 
Antirickettsial lymphokines may represent a mechanism of host defense against 
rickettsiae present within nonprofessional phagocytes. Inhibition of the growth 
and  survival  of R.  prowazekii  in  cultured  mouse  fibroblasts  occurs  when  the 
fibroblasts are treated with lymphokines produced by antigen- or concanavalin 
A-stimulated mouse spleen cells (1). Rickettsial growth is also inhibited in cultured 
human  fibroblasts,  endothelial  cells,  and  macrophages  when  these  cells  are 
treated  with culture supernatants  obtained  from antigen- or lectin-stimulated 
human peripheral blood leukocytes (1, 2). 
Several characteristics of the antirickettsial activity (ARA) in mouse lympho- 
kines are consistent with the hypothesis that this activity is due to interferon-~, 
(IFN-~,) (1,  3).  Like IFN-% ARA manifests species specificity or species prefer- 
ence, requires host cell protein synthesis for expression of activity, is relatively 
stable at 56°C, and is destroyed by exposure to pH 2, by trypsin, or by heating 
at 80°C. Furthermore, ARA is neutralized by antisera prepared against partially 
purified IFN-7 (3). In the present study, we present definitive evidence that IFN- 
~,  has  antirickettsial  activity:  cloned  mouse  IFN-~,  inhibits  the  growth  of R. 
prowazekii in mouse L929 cells. 
Materials and Methods 
Cell Cultures.  Mouse L929 cells were grown in Eagle's minimum essential medium 
supplemented with 10% calf serum or 10% fetal calf serum. Cultures of human foreskin 
fibroblasts were obtained from Mr. Frank Pindak, University of South Alabama, and were 
grown in Eagle's minimum essential medium supplemented with 10% fetal calf serum. All 
cells were grown in a CO2 incubator at 34°C. 
Rickettsiae.  Rickettsia prowazekii E  strain  was  prepared  from yolk sacs as  previously 
described (1). 
Cloned Mouse IFN-~, and Control Medium for Cloned IFN-'y.  Cloned mouse IFN-~, pro- 
duced by Chinese hamster ovary cells, control medium for this IFN-7 (CM), and cloned 
mouse IFN-7 produced by Escherichia coli were kindly provided by Dr. Patrick Gray and 
Dr. Gene Burton (Genentech, Inc., South San Francisco, CA). 
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Preparation of Lymphokines.  Lymphokines were prepared by culturing the spleen cells 
of Listeria  monocytogenes-chailenged  mice  in  the  presence  of concanavalin  A  for  24  h 
according to a  method modified from that of Havell et al. (4).  Briefly, C57BL/6J mice 
(8-15 wk old) were inoculated intravenously with 0.1  ml of saline that contained 1 ×  103 
Listeria monocytogenes. 7 d  later, spleen cells were cultured at a concentration of 1 ×  107 
cells/ml in  serum-free RPMI  1640  medium to  which  2  /Lg/ml  concanavalin A  (Sigma 
Chemical  Co.,  St.  Louis,  MO)  had  been added.  Seven  lymphokine preparations made 
according to this procedure contained 4,127-9,010  IU of interferon/ml (~ =  6,953). 
Interferon Assay.  A cytopathic effect inhibition assay modified from that of Haveil and 
Vilcek  (5)  as  described  previously (3)  was  used  for  measuring  IFN.  IFN  activity was 
calibrated against a  World  Health Organization international  reference preparation of 
mouse type I IFN (G-002-904-511) (National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, MD) and is expressed as international units. 
Treatment of Cells with Cloned IFN-% Infection of Cells with Rickettsiae, and Measurement of 
Rickettsial Growth.  Methods for x irradiation of cells, infection of cells, and measurement 
of rickettsial growth have been detailed previously (1). After x irradiation, L929 cells or 
human foreskin fibroblasts were adjusted to a density of 1.2 ×  105 viable ceils]ml, planted 
in  eight-chambered  slides  (0.3  ml/chamber)  (Lab-Tek  Div.,  Miles  Laboratories,  Inc., 
Naperviile, IL), and incubated overnight. The culture medium was then removed and 
the cells were treated for 24 h with medium alone or with medium that contained cloned 
IFN-~ or CM. Then, after the cells were infected with rickettsiae and washed, medium 
alone or medium  that contained cloned IFN-~, or CM  was added.  Infected cells were 
incubated at 34°C for up to 48 h. At 0, 24, and 48 h after infection, slides were dried, 
fixed, and stained by a modification of the Gimenez method, as previously described (1). 
Slides were examined microscopically with an oil immersion objective and the number of 
rickettsiae present in each of 100 cells was counted for each duplicate of each experimental 
treatment.  When a  cell contained >100  rickettsiae, it was assigned a  value of 100; this 
practice causes an underestimate of the number of rickettsiae at later times. The percent- 
age of cells infected with rickettsiae (%R), the average number of rickettsiae per infected 
cell (RI), and the average number of rickettsiae per cell (NR) were determined. The data 
were normalized to the zero time infection; e.g., RI at a given time divided by RI at 0 h 
multiplied by 100 gives the average number of rickettsiae per infected cell as a percentage 
of that observed at 0 h. 
Comparison of the  Effect of Cloned  IFN-'y  and  Crude  Mouse  Lymphokines  on  Rickettsial 
Growth.  Dilutions of IFN-'r or crude mouse lymphokines were made in eight-chambered 
Lab-Tek slides (150 #l/chamber). A suspension of irradiated L929 cells was infected with 
R. prowazekii, and washed, and 3.8  ×  104 cells in  150 #1 of tissue culture medium were 
added per chamber. Samples of the infected cell suspension were immediately cytocentri- 
fuged onto microscope slides,  dried, fixed, and stained. After incubation at 34°C for 48 
h, the chamber slides were also dried, fixed, and stained. Percent inhibition of rickettsial 
growth  in  the  treated  chambers  was calculated  from the  values  of NR at  48  h  after 
infection (expressed as percentages of the values of NR observed at 0 h).  At the time of 
each experiment, the IFN-~, and crude lymphokines were assayed for IFN. 
Results 
AIM of Cloned Mouse IFN-7.  During the 48-h period after infection, dramatic 
effects on  both  %R  and  RI  were  observed  in  R.  prowazekii-infected  L929  cell 
cultures that were treated with cloned mouse IFN-7 both 2't h  before and after 
infection (Fig.  1). Only 63% of the L929 cells that were infected at 0 h  remained 
infected at 48 h after infection in these IFN-'r-treated cultures (%R). In contrast, 
in control cultures or in cultures treated with CM both before and after infection, 
all of the cells that were infected at 0 h  remained infected at 48 h. RI underwent 
little  change  in  these  IFN-~r-treated  cultures  during  the  48  h  period  after 
infection; thus,  rickettsial growth was almost completely inhibited in the IFN-y- 
treated  cells  that  remained  infected  with  rickettsiae.  In  contrast,  rickettsial TURCO  AND  WINKLER  BRIEF  DEFINITIVE  REPORT  2161 
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FIGURE  l.  Effect  of treatment  of mouse L929 cells with cloned mouse IFN-~ or control 
medium for this IFN (CM) on the growth of R. prowazekii  in these cells. Cloned mouse IFN-~t 
produced by Chinese hamster ovary cells and CM were diluted in Eagle's minimum essential 
medium supplemented with 10% fetal calf serum. L929 cells were treated with cloned mouse 
IFN-7 (175 IU/0.3 ml) (D, [], R), CM (A), or tissue culture medium alone (O). The percentage 
of cells infected and  the average number  of rickettsiae per  infected cell are  expressed as 
percentages of the values observed at zero time. ([2]) Cells treated with IFN-'r 24 h before 
infection; (]~) cells treated with IFN-~. 24 h before and after infection; (i) cells treated with 
IFN-7 after infection; (A) cells treated with CM 24 h before and after infection. Each value 
represents the mean of two experiments. The percentage of cells infected at 0 h was 92 for 
control cells, 88 for cells treated with IFN-7 before infection, and 99 for cells treated with 
CM before infection. The average number of rickettsiae per infected cell at 0 h was 4.7 for 
control cells, 3.9 for cells treated with IFN-'r before infection, and 6.5 for cells treated with 
CM before infection. 
growth occurred in the control and CM-treated cultures: RI increased "~ 15-fold 
in the former and 9-fold in the latter. 
Less dramatic ARA was observed when  L929 cells were treated with cloned 
mouse IFN-3" either only before or only after  infection with R. prowazekii (Fig. 
1). In these cultures, rickettsial  growth was markedly inhibited, but most of the 
cells that were infected with rickettsiae  at 0  h  remained infected at 48 h  after 
infection. In cultures treated with IFN-3" only after infection, there was complete 
inhibition of rickettsial growth between 24 and 48 h after infection but inhibition 
was minimal or absent between 0 and 24 h after infection. 
Cycloheximide Suppression and Species Specificity of the ARA of Cloned Mouse IFN- 
3'.  Cycloheximide (1  #g/ml) markedly suppressed the inhibition of the growth 
of R. prowazekii by IFN-3" (produced by Chinese hamster ovary cells). During the 
48  h  period after  infection,  RI increased  15.5-fold in  untreated  cultures,  3.5- 
fold in cultures treated with IFN-3" (175 IU/0.3 ml) 24 h  before infection,  13.0- 
fold in cultures treated with IFN-7 and cycloheximide 24 h before infection, and 
16.4-fold in  cultures  treated  with  cycloheximide before infection  (two experi- 
ments  each).  The  values of %R in  these  cultures  at  48  h  after  infection were 
106, 90,  99, and  109%, respectively, of the values of %R observed at 0  h  after 
infection. 
Treatment of human foreskin fibroblasts with cloned mouse IFN-3" (produced 2162  TURCO  AND  WINKLER  BRIEF  DEFINITIVE  REPORT 
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FIGURE 2.  Inhibition of the growth of R. prowazekii in mouse L929 cells by various concen- 
trations of cloned mouse IFN-~,  or crude mouse lymphokines.  L929  cells infected with R. 
prowazekii were added to chamber slides that contained tissue culture medium alone, dilutions 
of cloned mouse  IFN-~,  produced  by  Chinese hamster ovary cells (&),  dilutions of cloned 
mouse IFN-7 produced by E.  coli (A),  or dilutions of crude mouse lymphokines (0).  After 
incubation for 48 h, the slides were fixed and stained. Rickettsial growth was monitored and 
percent inhibition of rickettsial growth was calculated as described in Materials and Methods. 
Lymphokines and cloned IFN-'r were assayed for IFN (antiviral activity) at the time of each 
experiment. Results of three experiments are shown. At 0 h after infection, the average values 
for %R and RI were 65 _  8 and 4.5 +  0.8, respectively. In the control cultures, NR increased 
15.1  4- 4.2-fold during the 48-h period after infection. 
by Chinese hamster ovary cells; 175 IU/0.3 ml), both before and after infection 
with R. prowazekii,  failed to inhibit rickettsial survival and growth in these cells. 
During the 48-h period after infection, %R increased slightly in all cultures and 
RI increased 16.3-fold in untreated cultures,  14.0-fold in IFN-~,-treated cultures, 
and  12.6-fold in CM-treated cultures (two experiments each). 
Comparison  of  the  ARA  of  Cloned  Mouse  IFN-~  and  Crude  Mouse  Lympho- 
kines.  Marked  inhibition  of rickettsial  growth  was apparent  in  chambers  that 
contained  as  few  as  5  IU  of IFN  as  cloned  mouse  IFN-7  or  crude  mouse 
lymphokines (Fig. 2). Cloned mouse IFN-~' produced by either Chinese hamster 
ovary cells or E. coli had identical dose-response curves. The percent inhibition 
of rickettsial  growth  in  cultures  treated  with  various concentrations  of crude 
mouse  lymphokines  plateaued  at  a  slightly  higher  value  (~-90%)  than  that 
observed in cultures treated with various concentrations of cloned mouse IFN-~ 
('~-80%).  Most of the ARA of the crude iymphokines can be accounted for by 
the IFN-~ that is present in the crude lympokines. However, some other minor 
antirickettsial  factor(s) may also be present in the crude lymphokines. 
Discussion 
The effects of cloned mouse IFN-~ on the survival and growth of R. prowazekii 
in mouse fibroblasts were similar to the effects of crude mouse lymphokines (1). 
In mouse L929 cells treated with either material 24 h before and after infection, 
the rickettsiae were cleared from some of the infected cells and rickettsial growth 
was suppressed in  the cells that  remained  infected.  Time was required  for the TURCO  AND  WINKLER  BRIEF  DEFINITIVE  REPORT  2163 
establishment of antirickettsial conditions within L929  cells by either material 
because rickettsial growth was more strongly inhibited during the first 24 h after 
infection in cells pretreated for 24  h  than in cells treated only after infection. 
Continued expression of the antirickettsial conditions induced by either material 
may  require  the  continued  presence  of the  material  since  the  antirickettsial 
effects observed in cells treated before and after infection were more pronounced 
than those observed in cells treated only before infection. Induction of antirick- 
ettsial conditions by either material was suppressed by cycloheximide, and neither 
the cloned mouse IFN-3, nor the crude mouse lymphokines induced antirickettsial 
conditions in human foreskin fibroblasts. 
Our previous work indicated that ARA and IFN--y have several characteristics 
in  common  (1,  3).  We  have shown  here  that  cloned  mouse  IFN-3,  induces 
antirickettsiai  conditions  in  mouse  fibroblasts.  Inhibition  of the  growth  of a 
protozoan  parasite,  Toxoplasma  gondii,  within  human  fibroblasts  treated  with 
cloned human IFN-3,  was recently reported (6).  Thus,  IFN-'r can induce anti- 
microbial activity against either prokaryotic or elJkaryotic microorganisms that 
grow within nonprofessional phagocytes. 
The effectiveness of IFN-3,  against R. prowazekii  in vivo remains to be deter- 
mined, but we speculate that production of IFN-3,  by sensitized T  lymphocytes 
may explain  (in  large  part)  the protective effect of adoptively transferred T 
lymphocytes or unfractionated spleen cells from immune animals against various 
rickettsial infections in animals (7-11).  Production of IFN-3,  has been demon- 
strated in immunized mice after challenge with viable R. tsutsugamushi (12). The 
induction of ARA in nonprofessional phagocytes (fibroblasts) by cloned IFN-7 
has been documented in this study, and provides a  mechanism for the control 
and elimination of R. prowazekii  sequestered within their principal host cells in 
vivo.  The  participation  of cloned  IFN-3,  in  macrophage activation  has  been 
demonstrated by other investigators (13), and we have found that treatment of 
mouse macrophage-like cells with cloned mouse IFN-3,  makes these cells unable 
to support the growth of R. prowazekii  (J. Turco, and H. H. Winkler, manuscript 
in preparation).  It seems likely that IFN-'y has a significant role in host defense 
against R. prowazekii  infections. 
Summary 
The  effect of treating cultured  mouse fibroblasts  (L929  cells)  with  cloned 
mouse interferon-3, on the growth of Rickettsia prowazekii  within the fibroblasts 
was studied. Within 48 h after infection, rickettsiae were cleared from a substan- 
tial proportion of the initially infected cells and rickettsial growth was inhibited 
in those cells that remained infected, when L929 cells were treated with cloned 
mouse  interferon-3,  both  before  and  after  infection.  When  L929  cells  were 
treated with cloned mouse interferon-7 either only before or only after infection 
with rickettsiae, rickettsial growth was markedly inhibited but rickettsiae were 
not cleared from many cells. Addition of cycloheximide to L929 cells markedly 
suppressed the antirickettsial activity of the interferon, and cloned mouse inter- 
fi~ron-3, did not induce antirickettsial activity in human foreskin fibroblasts. The 
antirickettsial effects of cloned mouse inteferon-3, were similar to those induced 
by crude mouse lymphokines prepared from concanavalin A-stimulated mouse 2164  TURCO  AND WINKLER  BRIEF  DEFINITIVE REPORT 
spleen cells. Equivalent amounts (units) of cloned mouse interferon-7 produced 
by Chinese hamster ovary cells or by Escherichia  coli caused equivalent inhibition 
of rickettsial growth in mouse fibroblasts.  However, at high concentrations of 
interferon-7, treatment of rickettsia-infected fibroblasts with equivalent amounts 
(units) of interferon-7, as crude mouse lymphokines or cloned mouse interferon- 
7,  resulted  in  slightly  greater  inhibition  of rickettsial  growth  by  the  crude 
lymphokines. Most of the antirickettsial activity of crude mouse lymphokines can 
be explained by the interferon-7 that is present in these preparations. Interferon- 
7, by virtue of its ability to inhibit rickettsial growth and effect the clearance of 
rickettsiae  from  nonprofessional  phagocytes,  may  play  a  crucial  role  in  the 
elimination of rickettsiae from the infected host. 
Received  for publication 2 August 1983 and in revised  form  14 September 1983. 
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